HPV Vaccination for MSM: Synthesis of the evidence and recommendations from the Québec Immunization Committee

References

• Sauvageau C, Gilca V. HPV Immunization of Québec Pre-Adolescents: Two or Three Doses? Québec, Canada: Institut national de santé publique du Québec, 2014, 68 p. Available at http://www.inspq.qc.ca/pdf/publications/1837_HPV_Immunization_PreAdolescents.pdf
   Google Scholar
• Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, Bocchini JA, Unger ER. Human papillomavirus vaccination. MMWR Recomm Rep 2014; 63(RR-05):1-30; PMID:25167164
   PubMed Web of Science ®Google Scholar
• Kirby T. UK committee recommends HPV vaccination for MSM. Lancet Oncol 2015; 16(1):e7; PMID:25638558; http://dx.doi.org/10.1016/S1470-2045(14)71128-3
   PubMedGoogle Scholar
• Bonanni P, Bechini A, Donato R, Capei R, Sacco C, Levi M, Boccalini S. Human papilloma virus vaccination: impact and recommendations across the world. Ther Adv Vaccines 2015; 3(1):3-12; PMID:25553242; http://dx.doi.org/10.1177/2051013614557476
   PubMedGoogle Scholar
• Babiuk S, Skowronski DM, De Serres G, HayGlass K, Brunham RC, Babiuk L. Aggregate content influences the Th1/Th2 immune response to influenza vaccine: evidence from a mouse model. J Med Virol 2004; 72(1):138-42; PMID:14635022; http://dx.doi.org/10.1002/jmv.10540
   PubMed Web of Science ®Google Scholar
• Giuliano AR, Salmon D. The case for a gender-neutral (universal) human papillomavirus vaccination policy in the United States: Point. Cancer Epidemiol Biomarkers Prev 2008; 17(4):805-8; PMID:18398020; http://dx.doi.org/10.1158/1055-9965.EPI-07-0741
   PubMed Web of Science ®Google Scholar
• Erickson LJ, De Wals P, Farand L. An analytical framework for immunization programs in Canada. Vaccine 2005; 23(19):2470-6; PMID:15752833; http://dx.doi.org/10.1016/j.vaccine.2004.10.029
   PubMed Web of Science ®Google Scholar
• Smith JS, Gilbert PA, Melendy A, Rana RK, Pimenta JM. Age-specific prevalence of human papillomavirus infection in males: a global review. J Adolesc Health 2011; 48(6):540-52; PMID:21575812; http://dx.doi.org/10.1016/j.jadohealth.2011.03.010
   PubMed Web of Science ®Google Scholar
• Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. Prevalence of HPV infection among men: A systematic review of the literature. J Infect Dis 2006; 194(8):1044-57; PMID:16991079; http://dx.doi.org/10.1086/507432
   PubMed Web of Science ®Google Scholar
• Machalek DA, Poynten M, Jin F, Fairley CK, Farnsworth A, Garland SM, Hillman RJ, Petoumenos K, Roberts J, Tabrizi SN, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol 2012; 13(5):487-500; PMID:22445259; http://dx.doi.org/10.1016/S1470-2045(12)70080-3
   PubMed Web of Science ®Google Scholar
• Mendez-Martinez R, Rivera-Martinez NE, Crabtree-Ramirez B, Sierra-Madero JG, Caro-Vega Y, Galvan SC, de Leon D, Garcia-Carranca A. Multiple human papillomavirus infections are highly prevalent in the anal canal of human immunodeficiency virus-positive men who have sex with men. BMC Infect Dis 2014; 14(1):671; PMID:25510243; http://dx.doi.org/10.1186/s12879-014-0671-4
   PubMed Web of Science ®Google Scholar
• Silverberg MJ, Lau B, Justice AC, Engels E, Gill MJ, Goedert JJ, Kirk GD, D'Souza G, Bosch RJ, Brooks JT, et al. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis 2012; 54(7):1026-34; PMID:22291097; http://dx.doi.org/10.1093/cid/cir1012
   PubMed Web of Science ®Google Scholar
• Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, Carter JJ, Porter PL, Galloway DA, McDougall JK. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004; 101(2):270-80; PMID:15241823; http://dx.doi.org/10.1002/cncr.20365
   PubMed Web of Science ®Google Scholar
• Giuliano AR, Palefsky JM, Goldstone S, Moreira ED, Jr., Penny ME, Aranda C, Vardas E, Moi H, Jessen H, Hillman R, et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med 2011; 364(5):401-11; PMID:21288094; http://dx.doi.org/10.1056/NEJMoa0909537
   PubMed Web of Science ®Google Scholar
• D'Souza G, Wiley DJ, Li X, Chmiel JS, Margolick JB, Cranston RD, Jacobson LP. Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 2008; 48(4):491-9; PMID:18614927; http://dx.doi.org/10.1097/QAI.0b013e31817aebfe
   PubMed Web of Science ®Google Scholar
• Institut de la statistique du Québec. L'Enquête québécoise sur la santé de la population, 2008: pour en savoir plus sur la santé des Québécois. Québec Institut de la statistique du Québec, 2010, 206 p.
   Google Scholar
• Statistique Canada. Les couples de même sexe et l'orientation sexuelle… en chiffres, [En ligne] 2014. Available at http://www.statcan.gc.ca/dai-quo/smr08/2014/smr08_189_2014-fra.htm ( page consultée le 12 novembre 2014).
   Google Scholar
• Ryan B, Berthiaume P. Les hommes ayant des relations sexuelles avec d'autres hommes (HARSAH) [En ligne] 2011. Available at http://www.espaceitss.ca/23-fiches-thematiques/les-hommes-ayant-des-relations-sexuelles-avec-d-autres-hommes-harsah-.html?pageEnCours=1&CATID=3
   Google Scholar
• Lambert G, Cox J, Miangotar Y, Tremblay C, Alary M, Otis J, Remis R, McGuire M, Sandstrom P. ARGUS Cycle 2008-2009: Enquête sur l'infection par le VIH, les hépatites virales et les infections transmissibles sexuellement et par le sang (ITSS) ainsi que sur les comportements à risques associés chez les hommes québécois ayant des relations sexuelles avec des hommes. Québec: Direction de santé publique, Agence de la santé et des services sociaux de Montréal, Institut national de santé publique du Québec et Agence canadienne de santé publique, 2011, 4 p.
   Google Scholar
• Agence de la santé publique du Canada. Surveillance améliorée de l'infection à VIH, des infections transmissibles sexuellement et par le sang et des comportements à risque associés chez les hommes ayant des relations sexuelles avec d'autres hommes au Canada. Ottawa: Agence de la santé publique du Canada, 2011, 72 p.
   Google Scholar
• Zou H, Tabrizi SN, Grulich AE, Garland SM, Hocking JS, Bradshaw CS, Morrow A, Prestage G, Cornall AM, Fairley CK, et al. Early acquisition of anogenital human papillomavirus among teenage men who have sex with men. J Infect Dis 2014; 209(5):642-51; PMID:24265440; http://dx.doi.org/10.1093/infdis/jit626
   PubMed Web of Science ®Google Scholar
• Meites E, Gorbach P, Gratzer B, Collins T, Panicker G, Steinau M, Parrish A, Randel C, Carrasco S, McGrath M, et al. Vaccine type HPV DNA and seroprevalence among young men who have sex with men, 2012-2013. Poster Presentation. 29th Annual International Papillomavirus Conference and Public Health & Clinical Workshops, Seattle, USA, 20-25 August, 2014.
   Google Scholar
• Carter JJ, Koutsky LA, Hughes JP, Lee SK, Kuypers J, Kiviat N, Galloway DA. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis 2000; 181(6):1911-9; PMID:10837170; http://dx.doi.org/10.1086/315498
   PubMed Web of Science ®Google Scholar
• Edelstein ZR, Carter JJ, Garg R, Winer RL, Feng Q, Galloway DA, Koutsky LA. Serum antibody response following genital {alpha}9 human papillomavirus infection in young men. J Infect Dis 2011; 204(2):209-16; PMID:21673030; http://dx.doi.org/10.1093/infdis/jir242
   PubMed Web of Science ®Google Scholar
• Joura EA, Leodolter S, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, Garland SM, Harper DM, Tang GW, Ferris DG, et al. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet 2007; 369(9574):1693-702; PMID:17512854; http://dx.doi.org/10.1016/S0140-6736(07)60777-6
   PubMed Web of Science ®Google Scholar
• Frazer IH. Measuring serum antibody to human papillomavirus following infection or vaccination. Gynecol Oncol 2010; 118(1 Suppl):S8-11; PMID:20494221; http://dx.doi.org/10.1016/j.ygyno.2010.04.003
   PubMedGoogle Scholar
• Dias D, Van Doren J, Schlottmann S, Kelly S, Puchalski D, Ruiz W, Boerckel P, Kessler J, Antonello JM, Green T, et al. Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18. Clin Diagn Lab Immunol 2005; 12(8):959-69; PMID:16085914
   PubMedGoogle Scholar
• Statistics Canada. Table 051-0001. 2015. Available at http://www5.statcan.gc.ca/cansim/a26?lang=eng&retrLang=eng&id=0510001&paSer=&pattern=&stByVal=1&p1=1&p2=37&tabMode=dataTable&csid=(Page accessed August 23, 2015)
   Google Scholar
• Ouhoummane N, Goggin P, Louchini R. Les infections au virus du papillome humain (VPH) et le portrait des cancers associés à ces infections au Québec. Québec: Institut national de santé publique du Québec, 2013, 86 p. + annexes.
   Google Scholar
• Aubin F, Pretet JL, Jacquard AC, Saunier M, Carcopino X, Jaroud F, Pradat P, Soubeyrand B, Leocmach Y, Mougin C, et al. Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV). Clin Infect Dis 2008; 47(5):610-5; PMID:18637758; http://dx.doi.org/10.1086/590560
   PubMed Web of Science ®Google Scholar
• Garland SM, Steben M, Sings HL, James M, Lu S, Railkar R, Barr E, Haupt RM, Joura EA. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis 2009; 199(6):805-14; PMID:19199546; http://dx.doi.org/10.1086/597071
   PubMed Web of Science ®Google Scholar
• Ministère de la Santé et des Services sociaux. Protocole d'immunisation du Québec. 6e édition: ministère de la Santé et des Services sociaux, [En ligne]. 2014. Available at http://msssa4.msss.gouv.qc.ca/fr/document/publication.nsf/4b1768b3f849519c852568fd0061480d/6335dde40226af59852575cc0048804d?OpenDocument
   Google Scholar
• Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009; 374(9686):301-14; PMID:19586656; http://dx.doi.org/10.1016/S0140-6736(09)61248-4
   PubMed Web of Science ®Google Scholar
• Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, Wheeler CM, Koutsky LA, Malm C, Lehtinen M, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005; 6(5):271-8; PMID:15863374; http://dx.doi.org/10.1016/S1470-2045(05)70101-7
   PubMed Web of Science ®Google Scholar
• Munoz N, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, et al. Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women. J Natl Cancer Inst 2010; 102(5):325-39; PMID:20139221; http://dx.doi.org/10.1093/jnci/djp534
   PubMed Web of Science ®Google Scholar
• The Future II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007; 356(19):1915-27; PMID:17494925; http://dx.doi.org/10.1056/NEJMoa061741
   PubMed Web of Science ®Google Scholar
• Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Steben M, Bryan J, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007; 356(19):1928-43; PMID:17494926; http://dx.doi.org/10.1056/NEJMoa061760
   PubMed Web of Science ®Google Scholar
• Palefsky JM, Giuliano AR, Goldstone S, Moreira ED Jr, Aranda C, Jessen H, Hillman R, Ferris D, Coutlee F, Stoler MH, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011; 365(17):1576-85; PMID:22029979; http://dx.doi.org/10.1056/NEJMoa1010971
   PubMed Web of Science ®Google Scholar
• Swedish KA, Factor SH, Goldstone SE. Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study. Clin Infect Dis 2012; 54(7):891-8; PMID:22291111; http://dx.doi.org/10.1093/cid/cir1036
   PubMed Web of Science ®Google Scholar
• Swedish KA, Goldstone SE. Prevention of anal condyloma with quadrivalent human papillomavirus vaccination of older men who have sex with men. PLoS One 2014; 9(4):e93393; PMID:24714693; http://dx.doi.org/10.1371/journal.pone.0093393
   PubMed Web of Science ®Google Scholar
• Coskuner ER, Ozkan TA, Karakose A, Dillioglugil O, Cevik I. Impact of the quadrivalent HPV vaccine on disease recurrence in men exposed to HPV Infection: a randomized study. J Sex Med 2014; 11(11):2785-91; PMID:25124237; http://dx.doi.org/10.1111/jsm.12670
   PubMed Web of Science ®Google Scholar
• Fairley CK, Hocking JS, Gurrin LC, Chen MY, Donovan B, Bradshaw CS. Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women. Sex Transm Infect 2009; 85(7):499-502; PMID:19837728; http://dx.doi.org/10.1136/sti.2009.037788
   PubMed Web of Science ®Google Scholar
• Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H, Wand H, Fairley CK. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis 2011; 11(1):39-44; PMID:21067976; http://dx.doi.org/10.1016/S1473-3099(10)70225-5
   PubMed Web of Science ®Google Scholar
• Read TR, Hocking JS, Chen MY, Donovan B, Bradshaw CS, Fairley CK. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect 2011; 87(7):544-7; PMID:21970896; http://dx.doi.org/10.1136/sextrans-2011-050234
   PubMed Web of Science ®Google Scholar
• Drolet M, Benard E, Boily MC, Ali H, Baandrup L, Bauer H, Beddows S, Brisson J, Brotherton JM, Cummings T, et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2015; 15:565-80; PMID:25744474
   PubMed Web of Science ®Google Scholar
• Rank C, Gilbert M, Ogilvie G, Jayaraman GC, Marchand R, Trussler T, Hogg RS, Gustafson R, Wong T. Acceptability of human papillomavirus vaccination and sexual experience prior to disclosure to health care providers among men who have sex with men in Vancouver, Canada: implications for targeted vaccination programs. Vaccine 2012; 30(39):5755-60; PMID:22796376; http://dx.doi.org/10.1016/j.vaccine.2012.07.001
   PubMed Web of Science ®Google Scholar
• Nadarzynski T, Smith H, Richardson D, Jones CJ, Llewellyn CD. Human papillomavirus and vaccine-related perceptions among men who have sex with men: a systematic review. Sex Transm Infect 2014; 90(7):515-23; PMID:24787367; http://dx.doi.org/10.1136/sextrans-2013-051357
   PubMed Web of Science ®Google Scholar
• Simatherai D, Bradshaw CS, Fairley CK, Bush M, Heley S, Chen MY. What men who have sex with men think about the human papillomavirus vaccine. Sex Transm Infect 2009; 85(2):148-9; PMID:19153110; http://dx.doi.org/10.1136/sti.2008.032581
   PubMed Web of Science ®Google Scholar
• Zou H, Grulich AE, Cornall AM, Tabrizi SN, Garland SM, Prestage G, Bradshaw CS, Hocking JS, Morrow A, Fairley CK, et al. How very young men who have sex with men view vaccination against human papillomavirus. Vaccine 2014; 32(31):3936-41; PMID:24852719; http://dx.doi.org/10.1016/j.vaccine.2014.05.043
   PubMed Web of Science ®Google Scholar
• Guay M, Clément P, Hamid A, Lemaire J, Sauvageau C, Dubé E, Vanier C, Boulianne N, Landry M. Évaluation de l'implantation du Programme de vaccination contre les VPH chez les adolescentes du Québec. Québec: Institut national de santé publique du Québec, 2012, 105 p. + annexes.
   Google Scholar
• Government of Canada. Health indicator profile, two year period estimates, by age group and sex, Canada, provinces, territories, health regions (2013 boundaries) and peer groups, 2015. Available at: http://www5.statcan.gc.ca/cansim/a26?Lang=fra&id=1050502&pattern=&p2=-1&stByVal=1&p1=1&tabMode=dataTable&paSer=&csid=&retrLang=eng&lang=eng
   Google Scholar
• Dufour A, Remis RS, Alary M, Otis J, Mâsse B, Turmel B, Vincelette J, Lavoie R, LeClerc R, Parent R, et al. Factors associated with hepatitis B vaccination among men having sexual relations with men in Montreal, Quebec, Canada. Sex Transm Dis 1999; 26(6):317-24; PMID:10417018; http://dx.doi.org/10.1097/00007435-199907000-00002
   PubMed Web of Science ®Google Scholar
• Reiter PL, Brewer NT. Hepatitis B vaccination among a national sample of gay and bisexual men. Sex Transm Dis 2011; 38(3):235-8; PMID:20842072; http://dx.doi.org/10.1097/OLQ.0b013e3181f422bb
   PubMed Web of Science ®Google Scholar
• Health Protection Agency. The HepB3 Study National Report: Annual Data for 2005 and 2006. London: Health Protection Agency, 2007, 5 p.
   Google Scholar
• van Rijckevorsel G, Whelan J, Kretzschmar M, Siedenburg E, Sonder G, Geskus R, Coutinho R, van den Hoek A. Targeted vaccination programme successful in reducing acute hepatitis B in men having sex with men in Amsterdam, the Netherlands. J Hepatol 2013; 59(6):1177-83; PMID:23954670; http://dx.doi.org/10.1016/j.jhep.2013.08.002
   PubMed Web of Science ®Google Scholar
• Medical Education Network. Managing inequities in protection against HPV-related disease through gender-neutral vaccination, 2012. Available at: http://www.mednet.ca/en/report/managing-inequities-in-protection-against-hpvrel.html (Page accessed September 1st, 2015)
   Google Scholar
• HPV Action. It's time to vaccinate boys too. The case for gender-neutral HPV vaccination, 2013. Available at: http://nomancampaign.org/HPV%20Action%20Case%20for%20Action.pdf ( Page accessed September 1st, 2015)
   Google Scholar
• Institut de la statistique du Québec. Naissances selon le sexe et rapport de masculinité à la naissance, Québec, 1986-2013, [En ligne] 2015. Available at: http://www.stat.gouv.qc.ca/statistiques/population-demographie/naissance-fecondite/451_sexe.htm (page consultée le 21 novembre 2014)
   Google Scholar
• Comité sur l'immunisation du Québec, HPV ad hoc scientific committee. HPV Vaccination in Québec: Knowledge Update and Expert Panel Proposals. Québec: Institut national de santé publique du Québec, 2013; 150 p. Available at: http://www.inspq.qc.ca/pdf/publications/1705_VaccVPHQc_MAJConnPropComiteExperts_VA.pdf.
   Google Scholar
• Kim JJ. Targeted human papillomavirus vaccination of men who have sex with men in the USA: a cost-effectiveness modelling analysis. Lancet Infect Dis 2010; 10(12):845-52; PMID:21051295; http://dx.doi.org/10.1016/S1473-3099(10)70219-X
   PubMed Web of Science ®Google Scholar
• National Advisory Committee on Immunization (NACI). Update on the recommended Human Papillomavirus (HPV) vaccine immunization schedule. Ottawa: Public Health Agency of Canada, 2015, 32.
   Google Scholar
• Alberta Government. Alberta to expand access to HPV vaccination, 2013. Available at: http://alberta.ca/release.cfm?xID=35503A3262125-A345-59F9-BCA57FD3EEF7375B (page accessed 21 november, 2014)
   Google Scholar
• Australian Governement. The Program, 2015. Available at: http://hpv.health.gov.au/the-program/
   Google Scholar
• Efrati I. Not just for girls: Israeli boys to receive HPV vaccinations too. HAARETZ 2015; Sivan 9:5775
   Google Scholar
• Grant K. Nova Scotia to include boys in HPV vaccination schedule, 2015. Available at http://www.theglobeandmail.com/life/health-and-fitness/health/nova-scotia-to-include-boys-in-hpv-vaccination-schedule/article23886885/
   Google Scholar
• Prince Edward Island Canada. HPV Vaccine Program expands to include boys, 2013. Available at: http://www.gov.pe.ca/health/index.php3?number=news&newsnumber=8937&lang=E
   Google Scholar
• Paré I. Vacciner les garçons malgré les coûts - L'INSPQ estime que les hommes gais sont laissés sans protection [En ligne] 2015. Available at: http://www.ledevoir.com/societe/sante/445657/vph-vacciner-les-garcons-malgre-les-couts ( Page consultée le 1er septembre 2015)
   Google Scholar